Unlocking these hidden metabolic pathways has proved an enduring challenge in plant biotechnology. A groundbreaking approach gaining traction involves the use of microbial co-cultures, where the symbiotic or competitive interactions between different organisms spur the biosynthesis of novel compounds not produced when cultured individually. This strategy has yielded remarkable success in microbial systems, particularly among bacteria and fungi, revolutionizing natural product discovery and biosynthesis. However, applying co-culture strategies to plant cells has faced significant hurdles, primarily because most bacterial species either inhibit growth or outright kill plant cell cultures, thereby limiting the repertoire of microbial partners that could safely stimulate plant metabolism.

The intriguing concept of leveraging endophytic bacteria—microorganisms living benignly within plant tissues—has recently been explored by a research team at Tokyo University of Science, Japan. Led by Professor Toshiki Furuya, this group focused on isolating these natural symbionts from Japanese mustard spinach (komatsuna) and Japanese radish (daikon), assessing their ability to coexist with cultured plant cells and activate novel metabolic processes. Unlike pathogenic or opportunistic bacteria, these endophytes possess an inherent compatibility that enables them to thrive inside plants without eliciting adverse effects, making them ideal candidates for co-culture experimentation with plant cell lines.

The research primarily utilized tobacco BY-2 cells, a ubiquitous model system in plant biology due to their fast growth and ease of genetic manipulation. Introducing the endophytic bacterium Delftia sp. BR1R-2 into these cultures revealed stunning results. Unlike common bacterial strains such as Escherichia coli that rapidly compromise plant cell viability, BR1R-2 flourished alongside the plant cells without causing damage. This coexistence hinted at a potentially symbiotic mechanism that might trigger the activation of silent metabolic genes within the plant cells.

Chemical analyses using high-performance liquid chromatography (HPLC) substantiated these interactions at the molecular level. The co-culture induced marked increases in acetophenone derivatives—small molecules recognized for their antimicrobial and pesticidal properties. Simultaneously, levels of N-caffeoylputrescine, a common phenolic amide abundant in tobacco cells, decreased, indicating a reallocation of metabolic resources toward producing new bioactive substances. Extracts from the co-cultured cells exhibited inhibitory effects against plant pathogens, confirming the functional potency of these novel metabolites in plant defense.

Further investigation employing gene expression profiling illuminated the underlying biological pathways modulated by the interaction. The presence of the endophytic bacteria elicited upregulation of multiple defense-related genetic networks regulated by plant hormones central to immune responses, such as salicylic acid and jasmonic acid pathways. Notably, the activation was contingent on physical contact between the bacterial cells and the plant cells, underscoring the importance of intimate cell-to-cell communication in triggering metabolic shifts.

Crucially, the phenomenon was not isolated to this single bacterial strain or plant model. Parallel experiments with Pseudomonas sp. RS1P-1, an endophyte derived from radish, generated comparable metabolic alterations when co-cultured with both tobacco and Arabidopsis plant cells. This cross-species consistency suggests that endophyte-mediated activation of plant metabolic pathways is a broadly applicable strategy, potentially extendable to a variety of economically significant plants.

Professor Furuya emphasizes the transformative implications of these findings: by harnessing plant immunity-activating endophytic bacteria, researchers can safely unlock a vast array of metabolic pathways previously inaccessible in cultured plant cells. This capability opens exciting avenues for the scalable production of diverse phytochemicals, circumventing the inefficiencies of whole-plant cultivation and enabling tailored synthesis of high-value compounds with pharmaceutical, cosmetic, and agricultural applications.

Moreover, this approach dovetails elegantly with green chemistry principles, offering an environmentally responsible approach to biosynthesis that reduces reliance on harsh chemical synthesis or unsustainable agricultural practices. The interplay between endophytic bacteria and plant cells orchestrates a dynamic metabolic landscape, fostering the biosynthesis of novel bioactive molecules with functional properties previously untapped in plant biotechnology.

The methodology holds promise not only for industrial bioproduction but also for advancing fundamental scientific understanding of plant-microbe interactions. By leveraging the natural symbiotic mechanisms evolved over millions of years, scientists can decode the complex regulatory networks that govern plant metabolism and immunity, potentially uncovering pathways that modulate stress resistance and secondary metabolite synthesis.

In summary, this pioneering research showcases a sophisticated biological system where endophytic bacteria act as stimulators of plant cell metabolic plasticity without compromising cell viability. The demonstrated capacity to induce dynamic shifts in metabolic profiles lays a robust foundation for future development of bioengineered plant cell cultures as renewable and controllable sources of valuable natural products.

As the agricultural and biotechnological sectors strive to meet the escalating global demand for sustainable natural compounds, the integration of endophytic bacterial co-cultures with plant cell culture platforms represents a compelling frontier. This synergy could ultimately revolutionize the production landscape for pharmaceuticals, nutraceuticals, cosmetics, and eco-friendly agrochemicals, encapsulating a new paradigm of bioinnovation at the interface of plant science and microbiology.

Subject of Research: Cells
Article Title: Plant Immunity–Activating Endophytic Bacteria Induce Dynamic Metabolic Changes in Cultured Plant Cells Without Inhibiting Their Growth
News Publication Date: 8-Jan-2026
References: DOI: 10.1111/1751-7915.70297
Image Credits: Professor Toshiki Furuya from Tokyo University of Science, Japan

Keywords

Plant cells, Green chemistry, Endophytes, Biotechnology, Microorganisms, Metabolites, Metabolic pathways, Biosynthesis

The starting point of this discovery lies in the vast genetic repositories that marine bacteria harbor. Streptomyces species are renowned for their prolific capacity to generate structurally diverse natural products with significant biological activities. Leveraging next-generation sequencing and sophisticated bioinformatic tools, the research team identified a previously uncharacterized biosynthetic gene cluster (BGC) in a marine Streptomyces strain, which hinted at the biosynthesis of a natural product incorporating a sulfenic acid functional group. This initial insight was pivotal, as sulfenic acids—characterized by a sulfur atom bonded to a hydroxyl group (–SOH)—have mainly been studied in synthetic chemistry and transient protein modifications. Their stable formation in natural small molecules had not been documented before, marking this investigation as a pioneering expedition into microbial chemistry’s unexplored terrain.

Elaborating on the biosynthetic route, the study revealed that sulfenicin arises from the intricate interplay of polyketide synthases (PKSs) and non-ribosomal peptide synthetases (NRPSs), modular enzyme complexes central to microbial secondary metabolism. These mega-enzymes orchestrate the assembly of complex molecules with extraordinary molecular precision. Within this hybrid PKS-NRPS assembly line, an unusual incorporation of sulfur is accomplished, ultimately resulting in the acylsulfenic acid functionality. Intriguingly, a key enzyme identified in the cluster is a flavin-dependent S-hydroxylase, a specialized oxygenase capable of hydroxylating sulfur atoms on thiocarboxylic acid intermediates. This enzymatic activity, analogous yet distinct from canonical hydroxylation reactions, imparts the critical chemical transformation that installs the reactive sulfenic acid moiety.

The elucidation of this enzymatic mechanism was supported by a multitude of experimental approaches, including heterologous expression of the gene cluster in amenable bacterial hosts, which enabled controlled biosynthesis and isolation of sulfenicin. Functional genetic manipulations delineated the roles of individual enzymes, while in vitro enzymatic assays recapitulated the hydroxylation steps, providing definitive proof of the biosynthetic logic. These comprehensive biochemical experiments demonstrated that the biosynthesis of acylsulfenic acid, far from being a fleeting synthetic curiosity, is an orchestrated biological process evolved by microbes to diversify their chemical repertoire.

Notably, this study highlights the unusual stability of the acylsulfenic acid functionality in sulfenicin. Sulfenic acids are typically reactive and transient in aqueous environments, often participating in redox signaling pathways or undergoing rapid conversions to disulfides or sulfinic acids. The structural context provided by the hybrid polyketide-peptide framework evidently stabilizes the sulfenic acid, allowing it to persist as a discrete functional group, which raises fascinating questions about its potential biological roles. Such stability may underlie unique biological activities of sulfenicin, including possible regulatory or defensive functions in the marine microbial milieu.

Furthermore, the investigation casts a spotlight on the distribution of acylsulfenic acid-forming enzymes across bacterial genomes. Although the specific sulfenicin biosynthetic cluster had no close analogs in public databases, homologous flavin-dependent S-hydroxylases that could catalyze sulfur hydroxylation are widely present in diverse bacterial taxa. This widespread occurrence suggests that acylsulfenic acid derivatives might constitute a broader, yet currently overlooked, class of natural products. Consequently, this discovery invites a reevaluation of microbial chemical space and predicts that many more sulfenic acid-containing compounds await characterization.

From a technical perspective, the research underscores the power of genome-guided natural product discovery, combining in silico genome mining, genetic engineering, and enzymology. The use of heterologous biosynthesis platforms not only circumvented challenges imposed by the native producing strain’s slow growth or genetic intractability but also allowed precise manipulation of biosynthetic steps. This integrated approach facilitated the isolation and structural elucidation of sulfenicin, using advanced spectroscopic techniques such as NMR and mass spectrometry, unveiling the molecule’s unprecedented sulfenic acid signature conclusively.

Clinically and industrially, the identification of stable acylsulfenic acid natural products holds tangible promise. Sulfur-containing bioactive molecules frequently exhibit unique pharmacological properties, including antimicrobial, anticancer, and enzymatic inhibitory activities. The sulfenic acid moiety’s redox-sensitive characteristics might enable sulfenicin to act as a redox modulator or a chemical signaling agent in microbial communities. Such properties could inspire the design of novel therapeutics targeting oxidative stress pathways or microbial interactions, making sulfenicin an attractive lead compound for future drug development programs.

Moreover, the detailed biochemical insights into S-hydroxylase catalysis expand our fundamental understanding of how enzymes evolve to harness reactive sulfur chemistries. This knowledge could drive biotechnological innovations, enabling synthetic biology approaches to engineer and diversify sulfur-containing molecules with tailored functionalities. Controlled enzymatic hydroxylation of sulfur may be harnessed to produce designer compounds with applications ranging from agriculture to material science, hence broadening the impact well beyond microbial natural products.

Equally compelling is the evolutionary implication of this discovery. Sulfur’s insertion into complex metabolites confers chemical diversity vital for ecological adaptation and chemical defense. The presence of specialized enzymes linking primary metabolism intermediates to novel secondary metabolites like sulfenicin indicates a sophisticated evolutionary strategy to exploit existing biochemical scaffolds. It reflects microbes’ relentless innovation in natural product biosynthesis and hints at an expansive chemical lexicon shaped by enzymatic creativity and genetic diversification.

The discovery also rekindles interest in the biosynthetic potential harbored by marine microorganisms. Marine Streptomyces and related taxa experience unique environmental pressures such as salinity, nutrient limitation, and microbial competition, which drive the evolution of chemically inventive pathways. As such, marine microbes represent a treasure trove of structural novelty and biochemical mechanisms. The revelation of sulfenicin thus exemplifies the untapped potential residing in marine microbial genomes and underscores the continuing value of bioprospecting in aquatic ecosystems.

While this work marks a significant milestone, it also poses myriad questions. The physiological role of sulfenicin within its native producer remains enigmatic, warranting further studies into its ecological function and biosynthetic regulation. Additionally, the stability and reactivity of acylsulfenic acids in vivo require careful examination, particularly in relation to their chemical interactions with cellular macromolecules. Addressing these questions will deepen our comprehension of sulfur chemistry in biology and guide efforts to harness these metabolites for human benefit.

In summary, the discovery of sulfenicin, a natural product featuring an acylsulfenic acid moiety, represents a paradigm shift in natural product chemistry and microbial metabolism. Through genome mining, sophisticated enzymology, and heterologous biosynthesis, this study illuminates a previously hidden sulfur chemistry pathway embedded within marine bacterial secondary metabolism. The widespread presence of related enzymes across bacterial species hints at a vast and unexplored landscape of sulfenic acid natural products, opening exciting frontiers for chemistry, biology, and biotechnology. As researchers continue to delve into this newfound sulfur domain, sulfenicin stands as a beacon for the unexpected chemical wonders that nature still has in store.

Subject of Research: Discovery and biosynthesis of a novel natural product featuring an acylsulfenic acid functionality in marine Streptomyces bacteria.

Article Title: Discovery of acylsulfenic acid-featuring natural product sulfenicin and characterization of its biosynthesis.

Article References:
Xue, D., Zou, H., Qiu, Y. et al. Discovery of acylsulfenic acid-featuring natural product sulfenicin and characterization of its biosynthesis. Nat. Chem. (2025). https://doi.org/10.1038/s41557-025-01833-9

Image Credits: AI Generated